Gene therapy vs no gene therapy controlPain symptom scores (VAS) ‐ change from baseline · peripheral arterial disease1 finding from 1 reviewGene therapy for peripheral arterial disease 2018 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 152 participantsVery low